Jab1/CSN5, a Component of the COP9 Signalosome, Regulates Transforming Growth Factor β Signaling by Binding to Smad7 and Promoting Its Degradation

REFERENCE

• Afrakhte, M., Moren A., Jossan S., Itoh S., Sampath K., Westermark B., Heldin C.-H., Heldin N. E., and ten Dijke P.. 1998. Induction of inhibitory Smad6 and Smad7 mRNA by TGF-β family members. Biochem. Biophys. Res. Commun. 249:505–511.
   PubMed Web of Science ®Google Scholar
• Attisano, L., and Wrana J. L.. 2000. Smads as transcriptional co-modulators. Curr. Opin. Cell Biol. 12:235–243.
   PubMed Web of Science ®Google Scholar
• Bae, M. K., Ahn M. Y., Jeong J. W., Bae M. H., Lee Y. M., Bae S. K., Park J. W., Kim K. R., and Kim K. W.. 2002. Jab1 interacts directly with HIF-1α and regulates its stability. J. Biol. Chem. 277:9–12.
   PubMed Web of Science ®Google Scholar
• Bech-Otschir, D., Seeger M., and Dubiel W.. 2002. The COP9 signalosome: at the interface between signal transduction and ubiquitin-dependent proteolysis. J. Cell Sci. 115:467–473.
   PubMed Web of Science ®Google Scholar
• Bianchi, E., Denti S., Granata A., Bossi G., Geginat J., Villa A., Rogge L., and Pardi R.. 2000. Integrin LFA-1 interacts with the transcriptional co-activator JAB1 to modulate AP-1 activity. Nature 404:617–621.
   PubMed Web of Science ®Google Scholar
• Bitzer, M., von Gersdorff G., Liang D., Dominguez-Rosales A., Beg A. A., Rojkind M., and Böttinger E. P.. 2000. A mechanism of suppression of TGF-β/SMAD signaling by NFκB/RelA. Genes Dev. 14:187–197.
   PubMed Web of Science ®Google Scholar
• Bonifacino, J. S., and Weissman A. M.. 1998. Ubiquitin and the control of protein fate in the secretory and endocytic pathways. Annu. Rev. Cell Biol. 14:19–57.
   Google Scholar
• Casellas, R., and Brivanlou A. H.. 1998. Xenopus Smad7 inhibits both the activin and BMP pathways and acts as a neural inducer. Dev. Biol. 198:1–12.
   PubMedGoogle Scholar
• Chauchereau, A., Georgiakaki M., Perrin-Wolff M., Milgrom E., and Loosfelt H.. 2000. JAB1 interacts with both the progesterone receptor and SRC-1. J. Biol. Chem. 275:8540–8548.
   PubMedGoogle Scholar
• Chen, H. I., and Sudol M.. 1995. The WW domain of Yes-associated protein binds a proline-rich ligand that differs from the consensus established for Src homology 3-binding modules. Proc. Natl. Acad. Sci. USA 9 2:7819–7823.
   Google Scholar
• Claret, F. X., Hibi M., Dhut S., Toda T., and Karin M.. 1996. A new group of conserved coactivators that increase the specificity of AP-1 transcription factors. Nature 383:453–457.
   PubMedGoogle Scholar
• Dechend, R., Hirano F., Lehman K., Heissmeyer V., Ansieau S., Wulczyn F. G., Scheidereit C., and Leutz A.. 1999. The Bcl-3 oncoprotein acts as a bridging factor between NF-κB/Rel and nuclear co-regulators. Oncogene 18:3316–3323.
   PubMed Web of Science ®Google Scholar
• Deng, X. W., Dubiel W., Wei N., Hofmann K., and Mundt K.. 2000. Unified nomenclature for the COP9 signalosome and its subunits: an essential regulator of development. Trends Genet. 16:202–203.
   PubMedGoogle Scholar
• Derynck, R., Zhang Y., and Feng X.-H.. 1998. Smads: transcriptional activators of TGF-β responses. Cell 95:737–740.
   PubMed Web of Science ®Google Scholar
• Deshaies, R. J. 1999. SCF and Cullin/Ring H2-based ubiquitin ligases. Annu. Rev. Cell Dev. Biol. 15:435–467.
   PubMed Web of Science ®Google Scholar
• Ebisawa, T., Fukuchi M., Murakami G., Chiba T., Tanaka K., Imamura T., and Miyazono K.. 2001. Smurf1 interacts with transforming growth factor-β type I receptor through Smad7 and induces receptor degradation. J. Biol. Chem. 276:12477–12480.
   PubMed Web of Science ®Google Scholar
• Eppert, K., Scherer S. W., Ozcelik H., Pirone R., Hoodless P., Kim H., Tsui L. C., Bapat B., Gallinger S., Andrulis I. L., Thomsen G. H., Wrana J. L., and Attisano L.. 1996. MADR2 maps to 18q21 and encodes a TGFβ-regulated MAD-related protein that is functionally mutated in colorectal carcinoma. Cell 86:543–552.
   PubMed Web of Science ®Google Scholar
• Fujii, M., Takeda K. T., Imamura H., Aoki T. K., Sampath S., Enomoto M., Kawabata M., Kato H., Ichijo H., and Miyazono K.. 1999. Roles of bone morphogenetic protein type I receptors and Smad proteins in osteoblast and chondroblast differentiation. Mol. Biol. Cell 10:3801–3813.
   PubMed Web of Science ®Google Scholar
• Glickman, M. H., Rubin D. M., Coux O., Wefes I., Pfeifer G., Cjeka Z., Baumeister W., Fried V. A., and Finley D.. 1998. A subcomplex of the proteasome regulatory particle required for ubiquitin-conjugate degradation and related to the COP9-signalosome and eIF3. Cell 94:615–623.
   PubMed Web of Science ®Google Scholar
• Hahn, S. A., Schutte M., Hoque A. T., Moskaluk C. A., da Costa L. T., Rozenblum E., Weinstein C. L., Fischer A., Yeo C. J., Hruban R. H., and Kern S. E.. 1996. DPC4, a candidate tumor suppressor gene at human chromosome 18q21. 1. Science 271:350–353.
   PubMed Web of Science ®Google Scholar
• Hayashi, H., Abdollah S., Qiu Y., Cai J., Xu Y.-Y., Grinnell B. W., Richardson M. A., Topper J. N., Gimbrone M. A., Jr., Wrana J. L., and Falb D.. 1997. The MAD-related protein Smad7 associates with the TGF-β receptor and functions as an antagonist of TGF-β signaling. Cell 89:1165–1173.
   PubMed Web of Science ®Google Scholar
• Heldin, C.-H., Miyazono K., and ten Dijke P.. 1997. TGF-β signalling from cell membrane to nucleus through SMAD proteins. Nature 390:465–471.
   PubMed Web of Science ®Google Scholar
• Hershko, A., and Ciechanover A.. 1998. The ubiquitin system. Annu. Rev. Biochem. 67:425–479.
   PubMed Web of Science ®Google Scholar
• Imamura, T., Takase M., Nishihara A., Oeda E., Hanai J.-I., Kawabata M., and Miyazono K.. 1997. Smad6 inhibits signaling by the TGF-β superfamily. Nature 389:622–626.
   PubMed Web of Science ®Google Scholar
• Itoh, S., Landstrom M., Hermansson A., Itoh F., Heldin C.-H., Heldin N.-E., and ten Dijke P.. 1998. Transforming growth factor β1 induces nuclear export of inhibitory Smad7. J. Biol. Chem. 273:29195–29201.
   PubMed Web of Science ®Google Scholar
• Kavsak, P., Rasmussen R. K., Caysing C. G., Bonni S., Zhu H., Thomsen G. H., and Wrana J. L.. 2000. Smad7 binds to Smurf2 to form an E3 ubiquitin ligase that targets the TGF-β receptor for degradation. Mol. Cell 6:1365–1375.
   PubMed Web of Science ®Google Scholar
• Kim, S.-J., Im Y.-H., Markowitz S. D., and Bang Y.-J.. 2000. Molecular mechanisms of inactivation of TGF-β receptors during carcinogenesis. Cytokine Growth Factor Rev. 11:159–168.
   PubMedGoogle Scholar
• Kleeff, J., Ishiwata T., Maruyama H., Friess H., Truong P., Buchler M. W., Falb D., and Korc M.. 1999. The TGF-β signaling inhibitor Smad7 enhances tumorigenicity in pancreatic cancer. Oncogene 18:5363–5372.
   PubMed Web of Science ®Google Scholar
• Kleemann, R., Hausser A., Geiger G., Mischke R., Burger-Kentischer A., Flieger O., Johannes F. J., Roger T., Calandra T., Kapurniotu A., Grell M., Finkelmeier D., Brunner H., and Bernhagen J.. 2000. Intracellular action of the cytokine MIF to modulate AP-1 activity and the cell cycle through Jab1. Nature 408:211–216.
   PubMed Web of Science ®Google Scholar
• Kwok, S. F., Solano R., Tsuge T., Chamovitz D. A., Ecker J. R., Matsui M., and Deng X. W.. 1998. Arabidopsis homologs of a c-Jun coactivator are present both in monomeric form and in the COP9 complex and their abundance is differentially affected by the pleiotropic cop/det/fus mutations. Plant Cell 10:1779–1790.
   PubMedGoogle Scholar
• Lallemand, F., Mazars A., Prunier C., Bertrand F., Kornprost M., Gallea S., Roman-Roman S., Cherqui G., and Atfi A.. 2001. Smad7 inhibits the survival nuclear factor κB and potentiates apoptosis in epithelial cells. Oncogene 20:879–884.
   PubMedGoogle Scholar
• Landstrom, M., Heldin N. E., Bu S., Hermansson A., Itoh S., ten Dijke P., and Heldin C. H.. 2000. Smad7 mediates apoptosis induced by transforming growth factor β in prostatic carcinoma cells. Curr. Biol. 10:535–538.
   PubMedGoogle Scholar
• Lin, X., Liang M., and Feng X.-H.. 2000. Smurf2 is a ubiquitin E3 ligase mediating proteasome-dependent degradation of Smad2 in transforming growth factor-β signaling. J. Biol. Chem. 275:36818–36822.
   PubMed Web of Science ®Google Scholar
• Markowitz, S. D., and Roberts A. B.. 1996. Tumor suppressor activity of the TGF-β pathway in human cancers. Cytokine Growth Factor Rev. 7:93–102.
   PubMedGoogle Scholar
• Massagué, J., and Chen Y. G.. 2000. Controlling TGF-β signaling. Genes Dev. 14:627–644.
   PubMed Web of Science ®Google Scholar
• Massagué, J., and Wotton D.. 2000. Transcriptional control by the TGF-β/Smad signaling system. EMBO J. 19:1745–1754.
   PubMed Web of Science ®Google Scholar
• McManus, M. T., and Sharp P. A.. 2002. Gene silencing in mammals by small interfering RNAs. Nat. Rev. Genet. 3:737–747.
   PubMed Web of Science ®Google Scholar
• Miyazono, K. 2000. Positive and negative regulation of TGF-β signaling. J. Cell Sci. 113:1101–1109.
   PubMed Web of Science ®Google Scholar
• Mizushima, S., and Nagata S.. 1990. pEF-BOS, a powerful mammalian expression vector. Nucleic Acids Res. 18:5322.
   PubMed Web of Science ®Google Scholar
• Nakao, A., Afrakhte M., Moren A., Nakayama T., Christian J. L., Heuchel R., Itoh S., Kawabata M., Heldin N.-E., Heldin C.-H., and ten Dijke P.. 1997. Identification of Smad7, a TGF-β-inducible antagonist of TGF-β signalling. Nature 389:631–635.
   PubMed Web of Science ®Google Scholar
• Okado, T., Terada Y., Tanaka H., Inoshita S., Nakao A., and Sasaki S.. 2002. Smad7 mediates transforming growth factor-β-induced apoptosis in mesangial cells. Kidney Int. 62:1178–1186.
   PubMed Web of Science ®Google Scholar
• Osterlund, M. T., Hardtke C. S., Wei N., and Deng X. W.. 2000. Targeted destabilization of HY5 during light-regulated development of Arabidopsis. Nature 405:462–466.
   PubMed Web of Science ®Google Scholar
• Pulaski, L., Landstrom M., Heldin C. H., and Souchelnytskyi S.. 2001. Phosphorylation of Smad7 at Ser-249 does not interfere with its inhibitory role in transforming growth factor-β-dependent signaling but affects Smad7-dependent transcriptional activation. J. Biol. Chem. 276:14344–14349.
   PubMed Web of Science ®Google Scholar
• Roberts, A. B., and Sporn M. B.. 1990. The transforming growth factor-βs, 419–472. In Sporn M. B. and Roberts A. B. (ed.), Peptide growth factors and their receptors, part I. Springer-Verlag, Heidelberg, Germany.
   Google Scholar
• Schwechheimer, C., and Deng X. W.. 2000. The COP/DET/FUS proteins—regulators of eukaryotic growth and development. Semin. Cell Dev. Biol. 11:495–503.
   PubMedGoogle Scholar
• Souchelnytskyi, S., Nakayama T., Nakao A., Morén A., Heldin C.-H., Christian J. L., and ten Dijke P.. 1998. Physical and functional interaction of murine and Xenopus Smad7 with bone morphogenetic protein receptors and transforming growth factor-β receptors. J. Biol. Chem. 273:25364–25370.
   PubMedGoogle Scholar
• Suzuki, C., Murakami G., Fukuchi M., Shimanuki T., Shikauchi Y., Imamura T., and Miyazono K.. 2002. Smurf1 regulates the inhibitory activity of Smad7 by targeting Smad7 to the plasma membrane. J. Biol. Chem. 277:39919–39925.
   PubMed Web of Science ®Google Scholar
• Tajima, Y., Goto K., Yoshida M., Shinomiya K., Sekimoto T., Yoneda Y., and Miyazono K.. 2003. Chromosomal region maintenance 1 (CRM1)-dependent nuclear export of Smad ubiquitin regulatory factor 1 (Smurf1) is essential for negative regulation of transforming growth factor-β signaling by Smad7. J. Biol. Chem. 278:10716–10721.
   PubMed Web of Science ®Google Scholar
• Tomoda, K., Kubota Y., and Kato J.-J.. 1999. Degradation of the cyclin-dependent-kinase inhibitor p27Kip1 is instigated by Jab1. Nature 398:160–165.
   PubMed Web of Science ®Google Scholar
• Tomoda, K., Kubota Y., Arata Y., Mori S., Maeda M., Tanaka T., Yoshida M., Yoneda-Kato N., and Kato J.-J.. 2002. The cytoplasmic shuttling and subsequent degradation of p27Kip1 mediated by Jab1/CSN5 and the COP9 signalosome complex. J. Biol. Chem. 277:2302–2310.
   PubMed Web of Science ®Google Scholar
• Ulloa, L., Doody J., and Massagué J.. 1999. Inhibition of transforming growth factor-β/SMAD signalling by the interferon-γ/STAT pathway. Nature 397:710–713.
   PubMed Web of Science ®Google Scholar
• Wan, M., Cao X., Bai S., Wu L., Shi X., Wang N., and Cao X.. 2002. Jab1 antagonizes TGF-β signaling by inducing Smad4 degradation. EMBO Rep. 3:171–176.
   PubMed Web of Science ®Google Scholar
• Wei, N., and Deng X. W.. 1999. Making sense of the COP9 signalosome. A regulatory protein complex conserved from Arabidopsis to human. Trends Genet. 15:98–103.
   PubMed Web of Science ®Google Scholar
• Wrana, J. L., Attisano L., Carcamo J., Zentella A., Doody J., Laiho M., Wang X.-F., and Massagué J.. 1992. TGF-β signals through a heteromeric protein kinase receptor complex. Cell 71:1003–1014.
   PubMed Web of Science ®Google Scholar
• Yamamura, Y., Hua X., Bergelson S., and Lodish H. F.. 2000. Critical role of Smads and AP-1 complex in transforming growth factor-β-dependent apoptosis. J. Biol. Chem. 275:36295–36302.
   PubMed Web of Science ®Google Scholar
• Yang, H.-Y., Zhou B. P., Hung M.-C., and Lee M.-H.. 2000. Oncogenic signals of HER-2/neu in regulating the stability of the cyclin-dependent kinase inhibitor p27. J. Biol. Chem. 275:24735–24739.
   PubMed Web of Science ®Google Scholar
• Zawel, L., Dai J. L., Buckhaults P., Zhou S., Kinzler K. W., Vogelstein B., and Kern S. E.. 1998. Human Smad3 and Smad4 are sequence-specific transcription activators. Mol. Cell 1:611–617.
   PubMed Web of Science ®Google Scholar
• Zhu, H., Kavsak P., Abdollah S., Wrana J. L., and Thomsen G. H.. 1999. ASMAD ubiquitin ligase targets the BMP pathway and affects embryonic pattern formation. Nature 400:687–693.
   PubMed Web of Science ®Google Scholar
• Zhu, H.-J., Iaria J., and Sizeland A. M.. 1999. Smad7 differentially regulates transforming growth factor β-signaling pathways. J. Biol. Chem. 274:32258–32264.
   PubMedGoogle Scholar